News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Shriners Hospitals For Children, Philadelphia Now Enrolling For Proneuron Biotechnologies, Inc. (US Branch)'s Phase II ProCord Study


10/19/2005 5:12:14 PM

Shriners Hospitals for Children, Philadelphia is now enrolling for Proneuron's Phase II trial of ProCord, for complete spinal cord injury. The official announcement was made at the Spinal Cord Injury Conference at Shriners Hospital in Philadelphia.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES